Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Journal of Alzheimer'S Disease : JAD|July 5, 2021
Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class AnalysisJulie Mouchet, Keith A Betts, Mihaela V Georgieva, et al.Advances in Therapy|September 2, 2021
Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and HyperkalemiaErin E Cook, Jill Davis, Rubeen Israni, et al.Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.Rheumatology and Therapy|November 24, 2021
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid ArthritisPhilip Conaghan, Stanley Cohen, Gerd Burmester, et al.Cancer|September 12, 2018
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 4-year follow-up and analysis of relative progression-free survival from the randomized ELOQUENT-2 trialMeletios A Dimopoulos, Sagar Lonial, Keith A Betts, et al.Clinical Drug Investigation|June 13, 2022
Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell CarcinomaDaniel M Geynisman, Mauricio Burotto, Camillo Porta, et al.Journal of Managed Care & Specialty Pharmacy|August 22, 2025
Changes in urine albumin-to-creatinine ratio and health care resource utilization and costs in patients with type 2 diabetes and chronic kidney diseaseKevin M Pantalone, Rakesh Singh, Aozhou Wu, et al.The Oncologist|September 20, 2022
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell CarcinomaBradley McGregor, Daniel M Geynisman, Mauricio Burotto, et al.BMJ Open Diabetes Research & Care|October 15, 2025
Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetesNavdeep Tangri, Rakesh Singh, Yan Chen, et al.Neurology and Therapy|April 15, 2021
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersElizabeth Faust, Irina Pivneva, Karen Yang, et al.Pageof 10